D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.2B |
| 2 |
NVIDIA
NVDA
|
+$1.02B |
| 3 |
T-Mobile US
TMUS
|
+$911M |
| 4 |
Netflix
NFLX
|
+$699M |
| 5 |
Micron Technology
MU
|
+$672M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$768M |
| 2 |
Robinhood
HOOD
|
+$643M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$534M |
| 4 |
Microsoft
MSFT
|
+$493M |
| 5 |
Intuit
INTU
|
+$472M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.33% |
| 2 | Healthcare | 8.66% |
| 3 | Consumer Discretionary | 8.33% |
| 4 | Financials | 6.44% |
| 5 | Industrials | 6.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1476
CALL
Charter Communications
CHTR
$17.3B
| $9.12M | 0.01% |
22,300
+1,400
| +7% | +$536K |
|
1477
Vornado Realty Trust
VNO
$7.65B
| $9.06M | 0.01% |
237,006
-93,195
| -28% | -$3.49M |
|
|
BCPC
1478
Balchem Corp
BCPC
$5.26B
| $9.04M | 0.01% |
56,761
-15,291
| -21% | -$2.48M |
|
|
OACC
1479
Oaktree Acquisition Corp III Life Sciences
OACC
$264M
| $9.03M | 0.01% |
861,625
| – | – |
|
1480
PUT
Visa
V
$677B
| $8.98M | 0.01% |
25,300
+15,000
| +146% | +$5.23M |
|
1481
Coursera
COUR
$1.77B
| $8.98M | 0.01% |
1,025,134
+186,254
| +22% | +$1.53M |
|
1482
Porch Group
PRCH
$1.35B
| $8.97M | 0.01% |
761,120
+509,815
| +203% | +$4.38M |
|
|
JMIA
1483
Jumia Technologies
JMIA
$708M
| $8.96M | 0.01% |
2,229,178
-875,821
| -28% | -$2.47M |
|
1484
Cameco
CCJ
$36.8B
| $8.96M | 0.01% |
120,659
+103,759
| +614% | +$5.54M |
|
1485
KLA
KLAC
$222B
| $8.96M | 0.01% |
100,000
-3,581,020
| -97% | -$269M |
|
|
FACT
1486
FACT II Acquisition Corp
FACT
$259M
| $8.95M | 0.01% |
866,244
+172,100
| +25% | +$1.74M |
|
|
RANG
1487
Range Capital Acquisition Corp
RANG
| $8.94M | 0.01% |
870,000
| – | – |
|
1488
CALL
Dick's Sporting Goods
DKS
$18.4B
| $8.94M | 0.01% |
45,200
+42,200
| +1,407% | +$7.82M |
|
1489
Vertex Pharmaceuticals
VRTX
$123B
| $8.94M | 0.01% |
20,081
-51,852
| -72% | -$23.9M |
|
1490
Deckers Outdoor
DECK
$14.1B
| $8.91M | 0.01% |
86,400
+10,048
| +13% | +$1.11M |
|
1491
Equinor
EQNR
$97.3B
| $8.89M | 0.01% |
353,640
-989,939
| -74% | -$23.9M |
|
1492
Crown Holdings
CCK
$13B
| $8.86M | 0.01% |
+86,079
| New | +$8.2M |
|
1493
Mativ Holdings
MATV
$479M
| $8.86M | 0.01% |
1,299,328
+141,363
| +12% | +$815K |
|
1494
Metropolitan Bank Holding Corp
MCB
$1.15B
| $8.85M | 0.01% |
126,427
-6,706
| -5% | -$415K |
|
1495
PUT
Levi Strauss
LEVI
$9.49B
| $8.82M | 0.01% |
477,200
+300,000
| +169% | +$4.99M |
|
1496
Evolus
EOLS
$397M
| $8.82M | 0.01% |
957,741
+80,680
| +9% | +$826K |
|
1497
Crane Co
CR
$11.9B
| $8.81M | 0.01% |
46,388
+32,010
| +223% | +$5.31M |
|
|
VNET
1498
VNET Group
VNET
$1.79B
| $8.8M | 0.01% |
1,275,287
-1,621,570
| -56% | -$9.71M |
|
|
NTWO
1499
Newbury Street II Acquisition Corp
NTWO
| $8.79M | 0.01% |
853,875
| – | – |
|
1500
Essent Group
ESNT
$6.28B
| $8.78M | 0.01% |
144,654
-82,767
| -36% | -$4.77M |
|
Similar funds
D.E. Shaw & Co's Q2 2025 Portfolio in Review
As of Q2 2025, D.E. Shaw & Co held 4,838 positions worth $141B, up 26% from $112B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
D.E. Shaw & Co deployed $7.51B of net new capital in Q2 2025, opening 647 new positions and adding to 1,556 existing holdings. Its largest new stake was Sea Limited: 1,365,221 shares worth $218M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was GE Vernova, an estimated $768M trimmed.
- D.E. Shaw & Co's largest Q2 2025 buy was Sea Limited: 1,365,221 shares worth $218M.
- D.E. Shaw & Co added most to Apple in Q2 2025, an estimated $1.2B increase.
- D.E. Shaw & Co's biggest Q2 2025 reduction was GE Vernova, cutting an estimated $768M.
- D.E. Shaw & Co fully exited Novo Nordisk in Q2 2025, selling an estimated $176M.
- D.E. Shaw & Co's ten largest holdings make up 12% of its $141B portfolio in Q2 2025.
- D.E. Shaw & Co opened 647 new positions and closed 532 in Q2 2025.
- D.E. Shaw & Co's portfolio value rose 26% quarter-over-quarter to $141B.
Based on D.E. Shaw & Co's 13F filing for Q2 2025, filed 14 Aug 2025.